Publication | Closed Access
Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study
62
Citations
41
References
2010
Year
Moxifloxacin monotherapy, 400 mg once daily for 14 days, is an effective and well-tolerated oral treatment for women with uPID.
| Year | Citations | |
|---|---|---|
Page 1
Page 1